Join the Risperdal Consta group to help and get support from people like you.
Risperdal Consta News
Long-Acting Injected Antipsychotics Help People With Schizophrenia Stay Out of Hospital
WEDNESDAY, Jan. 31, 2024 – For people with schizophrenia hospitalized after a psychotic episode, getting a long-acting antipsychotic injection works far better than pills to keep them from returning...
FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
SLOUGH, England and RICHMOND, Va., July 27, 2018 /PRNewswire/ – Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved Perseris, the first...
FDA Medwatch Alert: Risperdal (risperidone) and Risperidone: Recall - Uncharacteristic Odor
ISSUE: Ortho-McNeil-Janssen Pharmaceuticals notified healthcare professionals and the public of a recall of specific lots of Risperdal (risperidone) 3mg tablets and risperidone 2mg tablets. The ...
FDA Medwatch Alert: Risperidone (Risperdal) and Ropinirole (Requip): Medication Errors - Name Confusion
ISSUE: FDA notified healthcare professionals and the public of medication error reports in which patients were given risperidone (Risperdal) instead of ropinirole (Requip) and vice versa. In some...
FDA Medwatch Alert: Risperdal (risperidone) - Aug 4, 2004
FDA and Janssen revised the WARNINGS section of labeling, describing the increased risk of hyperglycemia and diabetes in patients taking Risperdal. MedWatch is posting a revised version of a letter...
FDA Medwatch Alert: Risperdal (risperidone) - Apr 25, 2003
Janssen Pharmaceutica and FDA revised the WARNINGS section of the prescribing information for Risperdal (risperidone), indicated for the treatment of schizophrenia. Cerebrovascular adverse events...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Bipolar Disorder, Schizophrenia